Xie Lihua,Zhao Sijun,Huang Min,et al.Global research of immunotherapy on allergic rhinitis:a bibliometric analysis[J].Journal of Clinical Pediatric Surgery,2023,22(12):1156-1163.[doi:10.3760/cma.j.cn101785-202309006-012]
基于Web of Science的免疫疗法治疗变应性鼻炎文献计量学分析
- Title:
- Global research of immunotherapy on allergic rhinitis:a bibliometric analysis
- Keywords:
- Rhinitis; Allergic; Seasonal; Immunotherapy; Bibliometrics
- 摘要:
- 目的 利用VOSviewer及CiteSpace等软件探索免疫疗法治疗变应性鼻炎的研究热点以及发展趋势。方法 使用Web of Science(WOS)核心数据库,检索免疫疗法治疗变应性鼻炎的相关文献并下载,运用VOSviewer和CiteSpace对文献的国家、机构、作者、关键词、引用情况进行可视化分析,运用WPS对相关数据进行统计分析。检索起止日期为1994年1月1日至2023年8月27日。结果 本研究共纳入文献2 846篇,其中发文量最多的是美国(567篇),发文量最多的机构是热那亚大学(102篇),且热那亚大学中心性达0.12,具有中介中心性;发文量排名前三的作者分别是Stephen R Durham(63篇),Giovanni Passalacqua(46篇),Oliver Pfaar(44篇);发文量排名前三的期刊分别是Allergy(222篇)、Journal of Allergy and Clinical Immunology(189篇)、Clinical and Experimental Allergy(141篇);关键词共现分析中,出现频次排名前三的分别是变异性鼻炎(allergic rhinitis,770次)、哮喘(asthma,362次)、舌下免疫治疗(sublingual immunotherapy,359次),提示变应性鼻炎与哮喘之间存在重要关联;关键词年度分布可视化图显示,近年研究热点有淋巴管内免疫疗法(intralymphatic immunotherapy)、皮下免疫疗法(subcutaneous immunotherapy)和免疫疗法(immunotherapy),其中淋巴管内免疫疗法排名第一。结论 免疫疗法治疗变应性鼻炎的研究热度持续,美国在该领域发表论文最多,居引领位置;在发文机构中,热那亚大学具有中介中心性,起枢纽作用,是潜在的合作对象。研究前沿为"淋巴管内免疫疗法",可重点关注,推动免疫疗法治疗变应性鼻炎的进一步进展,为变应性鼻炎的治疗提供新的有效方法。
- Abstract:
- Objective To employ OSviewer and CiteSpace to explore the development trends and research hotspots of allergic rhinitis (AR) in the field of immunotherapy.Methods Web of Science (WOS) core collection was searched and the literature related to immunotherapy and AR retrieved.VOSivewer and CiteSpace were utilized for visually analyzing the country,institution,author,keywords and citations of the literature.Results Among a total of 2 846 articles,the largest number of publications was the United States (567),institution with the largest number of publications University of Genoa (102) and centrality of University of Genoa 0.12.It attained betweenness centrality; Top 3 authors by number of publications were Stephen R Durham (63 articles),Giovanni Passalacqua (46 articles) and Oliver Pfaar (44 articles); Top 3 journals by number of publications were Allergy (222 articles),Journal of Allergy and Clinical Immunology (189 articles) and Clinical and Experimental Allergy (141 articles); Top 3 keywords were AR (770 times),asthma (362 times) and sublingual immunotherapy (359 times).It hinted at an important association between AR and asthma.From the perspective of overlay visualization.The hotspots were intralymphatic immunotherapy,subcutaneous immunotherapy and immunotherapy.The research frontier was intralymphatic immunotherapy.Conclusions Research popularity of immunotherapy for AR shall continue.The United States has published the most papers in this field and occupies a leading position.As for institutions,University of Genoa has betweenness centrality to play such a pivotal role that it is a potential institution to cooperate with.Research frontier of "intra-lymphatic immunotherapy" should be further explore for promoting the research advances of immunotherapy for AR.It can also provide solid theoretical rationales for offering a new and effective treatment of AR.
参考文献/References:
[1] 熊大经,刘蓬.中医耳鼻咽喉科学[M].第3版.北京:中国中医药出版社,2012:123-128. Xiong DJ,Liu P.Otolaryngology of Traditional Chinese Medicine[M].3rd Edition.Beijing:China Press of Traditional Chinese Medicine,2012:123-128.
[2] Hoyte FCL,Nelson HS.Recent advances in allergic rhinitis[J].F1000Res,2018,7(F1000 Faculty Rev):1333.DOI:10.12688/f1000research.15367.1.
[3] Zhang L,Han DM,Huang D,et al.Prevalence of self-reported allergic rhinitis in eleven major cities in China[J].Int Arch Allergy Immunol,2009,149(1):47-57.DOI:10.1159/000176306.
[4] Subspecialty Group of Rhinology,Editorial Board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery,Subspecialty Group of Rhinology,Society of Otorhinolaryngology Head and Neck Surgery,Chinese Medical Association:Chinese Guideline for Diagnosis and Treatment of Allergic Rhinitis (2022 Revision)[J].Chin J Otorhinolaryngol Head Neck Surg,2022,57(2):106-129.DOI:10.3760/cma.j.cn115330-20211228-00828.
[5] Mi JP,Chen XY,Lin XY,et al.Treatment of persistent allergic rhinitis via acupuncture at the sphenopalatine acupoint:a randomized controlled trial[J].Trials,2018,19(1):28.DOI:10.1186/s13063-017-2339-z.
[6] Li HB,Chen S,Cheng L,et al.Chinese guideline on sublingual immunotherapy for allergic rhinitis and asthma[J].J Thorac Dis,2019,11(12):4936-4950.DOI:10.21037/jtd.2019.12.37.
[7] Ji Z,Jiang FF.Efficacy and safety of sublingual immunotherapy for allergic rhinitis:a network meta-analysis[J].Front Immunol,2023,14:1144816.
[8] 俞辉,李卓扬,易银芝,等.先天性胫骨假关节的文献计量学分析[J].临床小儿外科杂志,2022,21(11):1049-1056.DOI:10.3760/cma.j.cn101785-202202041-010. Yu H,Li ZY,Yi YZ,et al.Top 100 classic research papers of congenital pseudarthrosis of the tibia:a bibliometric analysis[J].J Clin Ped Sur,2022,21(11):1049-1056.DOI:10.3760/cma.j.cn101785-202202041-010.
[9] Zeng YH,Xiao HQ,Gao SL,et al.Efficacy and immunological changes of sublingual immunotherapy in pediatric allergic rhinitis[J].World Allergy Organ J,2023,16(7):100803.DOI:10.1016/j.waojou.2023.100803.
[10] Liu WL,Zeng QX,He CH,et al.Compliance,efficacy,and safety of subcutaneous and sublingual immunotherapy in children with allergic rhinitis[J].Pediatr Allergy Immunol,2021,32(1):86-91.DOI:10.1111/pai.13332.
[11] Zeng QX,Zeng YH,Tang YQ,et al.Effect of IL-35 on apoptosis,adhesion,migration,and activation of eosinophils in allergic rhinitis[J].Pediatr Allergy Immunol,2022,33(2):e13717.DOI:10.1111/pai.13717.
[12] Zheng PY,Yan GY,Zhang YD,et al.Metabolomics reveals process of allergic rhinitis patients with single-and double-species mite subcutaneous immunotherapy[J].Metabolites,2021,11(9):613.DOI:10.3390/metabo11090613.
[13] Zhang YM,Wei P,Chen BB,et al.Intranasal fluticasone furoate in pediatric allergic rhinitis:randomized controlled study[J].Pediatr Res,2021,89(7):1832-1839.DOI:10.1038/s41390-020-01180-0.
[14] Chen H,Zhang L,Lou HF,et al.A randomized trial of comparing a combination of montelukast and budesonide with budesonide in allergic rhinitis[J].Laryngoscope,2021,131(4):E1054-E1061.DOI:10.1002/lary.28433.
[15] Chen H,Lou HF,Wang Y,et al.Comparison of the efficacy and mechanisms of intranasal budesonide,montelukast,and their combination in treatment of patients with seasonal allergic rhinitis[J].Int Forum Allergy Rhinol,2018,8(11):1242-1252.DOI:10.1002/alr.22197.
[16] Guo YH,Huang LR,Zhang L,et al.Early intervention improves clinical responses to seasonal allergic rhinitis by stimulation in sphenopalatine ganglion (Xinwu acupoint)[J].J Tradit Chin Med,2023,43(4):787-794.DOI:10.19852/j.cnki.jtcm.20230524.001.
[17] Song TT,Jing XH,Guo W,et al.Acupuncture for prevention of moderate to severe seasonal allergic rhinitis:a randomized controlled trial[J].Chin Acup Moxib,2023,43(2):123-127.DOI:10.13703/j.0255-2930.20220414-k0004.
[18] Bousquet J,Khaltaev N,Cruz AA,et al.Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization,GA(2)LEN and AllerGen)[J].Allergy,2008,63(Suppl 86):8-160.DOI:10.1111/j.1398-9995.2007.01620.x.
备注/Memo
收稿日期:2023-9-3。
基金项目:湖南省自然科学基金项目(2021JJ70078)
通讯作者:胡彬雅,Email:zhizi628@126.com